EMPOWER-Lung 1: Cemiplimab (CEMI) monotherapy as first-line (1L) treatment of patients ( pts) with brain metastases from advanced non-small cell lung cancer (aNSCLC) with programmed cell death-ligand 1 (PD-L1) >= 50%-3-year update

Kilickap S., ÖZGÜROĞLU M., Sezer A., GÜMÜŞ M., Bondarenko I., Gogishvili M., ...Daha Fazla

JOURNAL OF THORACIC ONCOLOGY, sa.4, 2023 (SCI-Expanded)

• Yayın Türü: Makale / Özet
• Basım Tarihi: 2023
• Dergi Adı: JOURNAL OF THORACIC ONCOLOGY
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
• İstanbul Üniversitesi Adresli: Hayır